echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > Ann Hematol: Gut microbiota score predicts survival after allogeneic hematopoietic stem cell transplantation

    Ann Hematol: Gut microbiota score predicts survival after allogeneic hematopoietic stem cell transplantation

    • Last Update: 2022-04-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a treatment option for hematological malignancies
    .


    In addition to malignancy recurrence, complications such as graft-versus-host disease (GVHD) and infection remain the leading causes of death, limiting the application of allo-HSCT


    Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a treatment option for hematological malignancies


    In this study, a research team prospectively obtained stool samples from patients undergoing allo-HSCT on day 15±1 post-transplantation, from 209 patients at two centers


    Figure 1: Schematic diagram of patients participating in this study

    Figure 1: Schematic diagram of patients participating in this study

    Figure 2: Four bacterial taxa selected for microbiota diversity and predicted survival
    .


    Diversity and ROC curves of different bacteria at day 15 post-transplantation were used to predict survival


    Figure 2: Four bacterial taxa selected for microbiota diversity and predicted survival


    Figure 3: Differences in microbiota abundance and composition at day 15 post-transplantation between groups
    .


    A Heat map of bacterial abundance in each group of patients


    Figure 3: Differences in microbiota abundance and composition at day 15 post-transplantation between groups


    Compared with high scores, low scores were associated with better 3-year cumulative overall survival (OS) and lower mortality (88.


    Figure 4: Cumulative gut microbiota (AIM) scores and their association with survival
    .


    The 3-year cumulative overall survival (OS, A ) and disease-free survival (DFS, B ) of the low group were longer than those of the high group


    Figure 4: Cumulative gut microbiota (AIM) scores and their association with survival


    Figure 5: Cumulative gut microbiota (AIM) scores predict survival
    .


    AIM score, cumulative gut microbiota score; AUC, area under receiver operating characteristic curve; ROC, receiver operating characteristic curve

    Figure 5: Cumulative gut microbiota (AIM) scores predict survival


    This study shows that gut microbiota scores can predict survival after allo-HSCT
    .
    Research data can guide clinicians in identifying patients at risk for serious mortality
    .
    In addition, these patients should consider and implement interventions to restore gut microbiota integrity, such as fecal microbiota transplantation or pre-emptive treatment strategies
    .
    These patients should consider and implement interventions to restore gut microbiota integrity, such as fecal microbiota transplantation or pre-emptive treatment strategies
    .

    Future studies will need to investigate the mechanisms by which the microbiota disrupts outcomes in greater depth, and larger prospective validation studies from multiple centers will be essential in the future
    .

    Future studies will need to investigate the mechanisms by which the microbiota disrupts outcomes in greater depth, and larger prospective validation studies from multiple centers will be essential in the future
    .

     

    Original source:

    Original source:

    Han, L.
    , Zhang, H.
    , Ma, P.
    et al.
     Intestinal microbiota score could predict survival following allogeneic hematopoietic stem cell transplantation.
      Ann Hematol  (2022).

    Han, L.
    , Zhang, H.
    , Ma, P.
      et al.
     Intestinal microbiota score could predict survival following allogeneic hematopoietic stem cell transplantation.
      Ann Hematol  (2022).
    et al.
    Ann Hematol leaves a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.